109 related articles for article (PubMed ID: 6781)
21. Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man.
Homeida M; Roberts C; Branch RA
Clin Pharmacol Ther; 1977 Oct; 22(4):402-9. PubMed ID: 902453
[TBL] [Abstract][Full Text] [Related]
22. Direct-gradient high-performance liquid chromatographic analysis and preliminary pharmacokinetics of flumequine and flumequine acyl glucuronide in humans: effect of probenecid.
Vree TB; van Ewijk-Beneken Kolmer EW; Nouws JF
J Chromatogr; 1992 Aug; 579(1):131-41. PubMed ID: 1447340
[TBL] [Abstract][Full Text] [Related]
23. Probenecid pharmacokinetics in cystic fibrosis.
Weber A; de Groot R; Ramsey B; Williams-Warren J; Smith A
Dev Pharmacol Ther; 1991; 16(1):7-12. PubMed ID: 1879255
[TBL] [Abstract][Full Text] [Related]
24. New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuterium-labelled DEHP.
Koch HM; Bolt HM; Preuss R; Angerer J
Arch Toxicol; 2005 Jul; 79(7):367-76. PubMed ID: 15700144
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of bethanidine in hypertensive patients.
Shen D; Gibaldi M; Israili A; Bellward G; Cunningham R; Throne M; Dayton P; McNay J
Clin Pharmacol Ther; 1975 Mar; 17(3):363-73. PubMed ID: 1120401
[TBL] [Abstract][Full Text] [Related]
26. Metabolism of flecainide.
Conard GJ; Ober RE
Am J Cardiol; 1984 Feb; 53(5):41B-51B. PubMed ID: 6364769
[TBL] [Abstract][Full Text] [Related]
27. Determination of indomethacin, its metabolites and their glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatographic analysis. Preliminary pharmacokinetics and effect of probenecid.
Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
J Chromatogr; 1993 Jul; 616(2):271-82. PubMed ID: 8376508
[TBL] [Abstract][Full Text] [Related]
28. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics, metabolism and renal excretion of sulfatroxazole and its 5-hydroxy- and N4-acetyl-metabolites in man.
Vree TB; Hekster YA; Tijhuis MW; Termond EF; Nouws JF
Biopharm Drug Dispos; 1986; 7(3):239-52. PubMed ID: 3730524
[TBL] [Abstract][Full Text] [Related]
30. Probenecid-induced changes in the clearance of pranoprofen enantiomers.
Imai T; Nomura T; Otagiri M
Chirality; 2003 May; 15(4):318-23. PubMed ID: 12666238
[TBL] [Abstract][Full Text] [Related]
31. Probenecid-impaired biliary excretion of acetaminophen glucuronide and sulfate in the rat.
Savina PM; Brouwer KL
Drug Metab Dispos; 1992; 20(4):496-501. PubMed ID: 1356724
[TBL] [Abstract][Full Text] [Related]
32. Low-dose probenecid selectively inhibits urinary excretion of phenolsulfonphthalein in rats without affecting biliary excretion.
Shin YJ; Lee JH; Oh JH; Lee YJ
J Appl Toxicol; 2013 Jun; 33(6):511-5. PubMed ID: 22161506
[TBL] [Abstract][Full Text] [Related]
33. Metabolism and excretion of ropivacaine in humans.
Halldin MM; Bredberg E; Angelin B; Arvidsson T; Askemark Y; Elofsson S; Widman M
Drug Metab Dispos; 1996 Sep; 24(9):962-8. PubMed ID: 8886605
[TBL] [Abstract][Full Text] [Related]
34. Urinary elimination of nitrazepam and its main metabolites.
Kangas L
Acta Pharmacol Toxicol (Copenh); 1979 Jul; 45(1):16-9. PubMed ID: 474153
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of beta-methyldigoxin in healthy humans II: Oral studies and bioavailability.
Hinderling PH; Garrett ER; Wester RC
J Pharm Sci; 1977 Mar; 66(3):314-25. PubMed ID: 845795
[TBL] [Abstract][Full Text] [Related]
36. Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers.
Stass H; Sachse R
Clin Pharmacokinet; 2001; 40 Suppl 1():71-6. PubMed ID: 11352445
[TBL] [Abstract][Full Text] [Related]
37. Effect of urinary pH on the pharmacokinetics of salicylic acid, with its glycine and glucuronide conjugates in human.
Vree TB; Van Ewijk-Beneken Kolmer EW; Verwey-Van Wissen CP; Hekster YA
Int J Clin Pharmacol Ther; 1994 Oct; 32(10):550-8. PubMed ID: 7834163
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic evaluation of drug interactions with zidovudine. I: Probenecid and zidovudine in monkeys.
Qian MX; Finco TS; Mehta M; Viswanathan CT; Gallo JM
J Pharm Sci; 1991 Nov; 80(11):1007-11. PubMed ID: 1815049
[TBL] [Abstract][Full Text] [Related]
39. Probenecid and the rat kidney: investigations by renal enzyme excretion technique.
Raab WP; Moerth CM
Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):120-2. PubMed ID: 1254375
[TBL] [Abstract][Full Text] [Related]
40. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
Kim KA; Oh SO; Park PW; Park JY
Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
